FDA’s chief drug regulator steps down following federal investigation into ‘significant concerns’
Dr. George Tidmarsh, head of the FDA’s drug center, abruptly resigned due to “serious concerns about his personal conduct.” This came after officials started reviewing issues related to his behavior. Tidmarsh was placed on leave and later resigned, with allegations of making false statements during his time at the FDA. A lawsuit by Aurinia Pharmaceuticals claimed he targeted the company’s board chair, Kevin Tang, and made negative remarks about their kidney drug. Tidmarsh’s departure adds to previous leadership changes at the FDA, which has faced controversy over decisions on vaccines and other products. The FDA’s drug center has also experienced significant staff turnover.
#FDA #FDAresignation #GeorgeTidmarsh #AuriniaPharmaceuticals #FDAleadership #pharmaceuticalindustry #biotech #FDAregulation #healthnews #FDAcontroversy #vaccineapproval #drugcenter #FDAoversight #FDAreview #FDAethics #pharmaceuticalcompanies #leadershipchanges
Visit: Source link
#NFL #NFLNews #Sports #Football #Soccer #FDAs #top #drug #regulator #resigns #federal #officials #probe #concerns